2Ohta M, Inoue H, Cottieelli MG, et al.The FHIT gene, spanning the chromosome 3p14. 2 fragile site and renal carcinoma- associated t (3 ; 8) breakpoint, is abnormal in digestive tract cancers. Cell,1996, 84: 587-597.
3Chen J, Brevet A, Blanquet S, et al.Control of 5' 5'-dinucleoside triphosphate catabolism by APH1, a saccharomyces cerevisiae analog of human FHIT. J Bacteriol, 1998, 180: 2345-2349.
4Yuan BZ, Keek-Waggoner C, Zimonjic DB, et al. Alterations of the FHIT gene in human hepatocellular carcinoma. Cancer Res, 2000, 60: 1049-1053.
5Bringuier PP, Tamimi Y, Schuuring E, et al. Expression of cyclin D1 and EMS1 in bladder tumours; relationship with chromosome 11q13 amplification. Oncogene, 1996,12:1747-1753.
6Scully C, Field JK, Tanzawa H. Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN):1.Carcinogen metabolism, DNA repair and cell cycle control. Oral Oncol, 2000, 36:256-263.
7Liu SC, Klein-Szanto AJ. Markers of proliferation in normal and leukoplakic oral epithelia. Oral Oncol, 2000, 36:145-151.
8Huang X, Gollin SM, Raja S, et al. High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells. Proc Natl Acad Sci U S A, 2002, 99:11369-11374.
9Schuuring E, van Damme H, Schuuring-Scholtes E, et al. Characterization of the EMS1 gene and its product, human Cortactin. Cell Adhes Commun, 1998, 6:185-209.
10Rodrigo JP, Garcia LA, Ramos S, et al. EMS1 gene amplification correlates with poor prognosis in squamous cell carcinomas of the head and neck. Clin Cancer Res, 2000, 6:3177-3182.
